Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy
暂无分享,去创建一个
Sheng-Nan Lu | R. Chien | W. Su | C. Peng | W. Chuang | Sien‐Sing Yang | A. Qin | Chao-Wei Hsu | Yi-Wen Huang | Tzong-Hsi Lee | Pei‐Jer Chen | K. Tseng | Hsien‐Hong Lin | Shih-Jer Hsu | Jaw‐Ching Wu | Tzong‐Hsi Lee